News | Cath Lab | May 24, 2016

SCAI 2016 Late-breaking Trial Presesentations

The latest interventional cardiology trial data presented at the Society for Cardiovascular Angiography and Interventions 2016 Scientific Sessions

 

The Society for Cardiovascular Angiography and Interventions (SCAI) 2016 Scientific Sessions took place May 4-7, 2016 in Orlando, Fla. The event included data from clinical trials on some of the latest advances in interventional cardiology. The late-breaking clinical trials presentations include the following, including links to related stories on these trials:

Wednesday, May 4, 1:15 - 2:15 p.m. Eastern Time

• Effect of the AVERT Contrast Modulation System on Contrast Dose Reduction and Acute Kidney Injury After Coronary Angiography and PCI, presented by Roxana Mehran, M.D., FSCAI.

• Clinical Evaluation of the Cadence Device in the Acoustic Detection of Coronary Artery Disease: The TURBULENCE Study, presented by Joseph Thomas, M.D., FSCAI.

• Demonstration of the Safety and Feasibility of Robotically Assisted Percutaneous Coronary Intervention in Complex Coronary Lesions: Results of the Complex Robotically Assisted Percutaneous Coronary Intervention (CORA-PCI) Trial, presented by Ehtisham Mahmud, M.D., FSCAI.

• Risk Directed Interventions in Percutaneous Coronary Intervention (PCI):  An Enterprise Approach for Reducing Bleeding Events, presented by Jerome E. Granato, M.D.

 

Thursday, May 5, 10:30 - 11:30 a.m. Eastern Time
 Plaque Morphology Predictors of Side Branch Occlusion after Provisional Stenting in Coronary Bifurcation Lesion: Results of Optical Coherence Tomography Bifurcation Study (ORBID), presented by Annapoorna Kini, M.D.

• Final Results for THE ATHENA TRIALS: Autologous Adipose Derived Regenerative Cells (ADRCs) for Refractory Chronic Myocardial Ischemia with Left Ventricular (LV) Dysfunction, presented by Timothy D. Henry, M.D., MSCAI.

• Efficacy of STENTYS Self-Apposing Bare Metal Nitinol Stents in Patients Undergoing Primary PCI: Results from the APPOSITION V Trial, presented by Roxana Mehran, M.D., FSCAI.

• Final Results for the Renew Trial: A Phase 3, Randomized, Double Blinded, Active-Controlled, Unblinded Standard of Care Study Assessing the Efficacy and Safety of Intramyocardial Autologous CD34+ Cell Administration in Patients with Refractory Angina, presented by Timothy D. Henry, M.D., MSCAI.

 

Friday, May 6 | 9:00 a.m. to 10:00 a.m. Eastern Time
• Sex Based Differences in Outcomes With Transcatheter Aortic Valve Therapy: From the STS/ACC TVT Registry, presented by Roxana Mehran, M.D., FSCAI.

• Sex-Based Differences in Patients Less than 50 Years of Age Undergoing PCI for Acute Coronary Syndromes, presented by Jaya Chandrasekhar, MBBS.

• Moderate vs. General Anesthesia for Transcatheter Aortic Valve Replacement: An STS/ACC Transcatheter Valve Therapy Registry Analysis, presented by Jay Giri, M.D., MPH.

• Sex Based Differences in Outcomes with Bivalirudin or Unfractionated Heparin for Transcatheter Aortic Valve Replacement: Results from the BRAVO 3 Randomized Trial, presented by Anita W. Asgar, M.D.

For more information on the late-breaking trials and featured clinical research being presented at the meeting, visit: www.scai.org/SCAI2016LBCT.  

Related Content

Shockwave Announces Collaboration With Abiomed on Physician Training
News | Cath Lab | December 14, 2018
Shockwave Medical announced a new investment and collaboration agreement with Abiomed Inc. As outlined by the agreement...
Sponsored Content | Videos | Cath Lab | October 24, 2018
Michael Flaherty, M.D., discusses a study published in Circulation Research which finds that use of hemodynamic suppo
Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) datab
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and tre
Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
Overlay Init